Amelioration of streptozotocin-induced diabetes mellitus, oxidative stress and dyslipidemia in rats by tomato extract lycopene

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 69, Issue 3, 2009, Pages 371-379

  Ali, Mamdouh M ^a   Agha, Fatma G ^b  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b AL AZHAR UNIVERSITY   (Egypt)

Author keywords

Antioxidative enzymes; Hyperglycaemia; Lipid peroxidation; Lipid profile; Lycopene

Indexed keywords

ANTIDIABETIC AGENT; ANTIOXIDANT; CATALASE; GLUCOSE; GLUTATHIONE PEROXIDASE; INSULIN; LIPID; LYCOPENE; OXIDOREDUCTASE; STREPTOZOCIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; CAROTENOID; HYDROGEN PEROXIDE; NITRIC OXIDE; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DYSLIPIDEMIA; ENZYME ACTIVITY; ERYTHROCYTE; HYPERGLYCEMIA; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; TOMATO; ANIMAL; BLOOD; CHEMISTRY; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; ISOLATION AND PURIFICATION; METABOLISM; PANCREAS; SPRAGUE DAWLEY RAT;

LYCOPERSICON ESCULENTUM; RATTUS;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; CAROTENOIDS; DIABETES MELLITUS, EXPERIMENTAL; DYSLIPIDEMIAS; ERYTHROCYTES; HYDROGEN PEROXIDE; INSULIN; LIPIDS; LYCOPERSICON ESCULENTUM; MALE; NITRIC OXIDE; OXIDATIVE STRESS; PANCREAS; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 67649683053     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510802658473     Document Type: Article

References (61)

1. American Diabetes Association. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications (Position Statement). Diabetes Care 2003;26Suppl 1:S51-61.
2. Yajnik CS. The insulin resistance epidemic in India: fetal origins, later lifestyle, or both? Nutritional Rev 2001;59:1-9.
3. Banfi C, Eriksson P, Giandomenico G, Mussoni L, Sironi L, Hamsten A, Tremoli E. Transcriptional regulation of PAI-1 gene by insulin. Diabetes 2001;50:1522-30.
4. Barnett P, Braunstein GD. Diabetes mellitus. In: Andreoli TE, Carpenter CCJ, Griggs RC, Loscalzo J, editors. Cecil essentials of medicine, 5th edn. Philadelphia: W. B. Saunders; 2001.
5. Larner J. Insulin and oral hypoglycemic drug, glucogan. In: Gilman AG, Goodman LS, Rall IW, Murad F, editors. The pharmacological basis of therapeutics, 7th edn. NewYork: Macmillan; 1985. p. 1490-516.
6. The WHO Expert Committee on Diabetes Mellitus. Technical Report Series World Health Organization, Geneva; 1980.
7. Opara EC. Oxidative stress, micronutrients, diabetes mellitus and its complications. J R Soc Health 2002;122:28-34.
8. Abou-Seif MAM, Youssef H. Oxidative stress and male IGF-1, gonadotropin and related hormones in diabetic patients. Clin Chem Lab Med 2001;39:618-23.
9. Velazquez E, Winocour PH, Kesteven P, Alberti KG, Laker MF. Relation of lipid peroxides to macrovascular disease in type 2 diabetes. Diabet Med 1991;8:752-8.
10. Moncado S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-42.
11. Abdel-Naim AB, Abdel-Wahab MH, Attia FF. Protective effects of vitamin E and probucol against gentamicin-induced nephrotoxicity in rats. Pharmacol Res 1999;40:183-7.
12. McCall MR, Frei B. Can antioxidant vitamins materially reduce oxidative damage in humans? Free Radic Biol Med 1999;7/8:1034-53.
13. Maldonado PD, Barrera D, Medina-Campos ON, Hernandez-Pando R, Ibarra-Rubio ME, Pedraza-Chaverri J. Aged garlic extract attenuates gentamicin-induced renal damage and oxidative stress in rats. Life Sci 2003;73:2543-56.
14. Pedraza-Chaverri J, Gonzalez-Orozco AE, Maldonado PD, Barrera D, Medina-Campos ON, Hernandez-Pando R. Diallyl disulfide ameliorates gentamicin-induced oxidative stress and nephropathy in rats. Eur J Pharmacol 2003;473:71-8.
15. Cohen LA. A review of animal model studies of tomato carotenoids, lycopene, and cancer chemoprevention. Exp Biol Med 2002;227:864-8.
16. Tapiero H, Townsend DM, Tew KD. The role of carotenoids in the prevention of human pathologies. Biomed Pharmacother 2004;58:100-10.
17. Gerster H. The potential role of lycopene for human health. J Am Coll Nutr 1997;16:109-26.
18. Rao AV, Agarwal S. Role of lycopene as antioxidant carotenoid in the prevention of chronic diseases: a review. Nutrition Res 1999;19:305-23.
19. Zhang LX, Cooney RV, Bertram JS. Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: relationship to their cancer chemopreven-tive action. Carcinogenesis 1991;12:2109-14.
20. Levy J, Bosin E, Feldman B, Giat Y, Miinster A, Danilenko M, Sharoni Y. Lycopene is a more potent inhibitor of human cancer cell proliferation than either alfa-carotene or beta-carotene. Nutr Cancer 1995;24:257-66.
21. Lingen C, Ernster L, Lindberg O. The promoting effect of lycopene on the nonspecific resistance of animals. Exp Cell Res 1959;16:384-93.
22. Bell RH, Hye RJ. Animal models of diabetes mellitus: physiology and pathology. J Surg Res 1983;35:433-60.
23. Mayhan WG, Simmons LK, Sharpe GM. Mechanism of impaired responses of cerebral arteriols during diabetes mellitus. Am J Phys 1991;260:319-26.
24. Diwadkar-Navsariwala V, Novotny Dura J, Gustin GM, Rodvold KA, Crowell AJ, Sosman JA, Stacewicz-Sapuntzaki J, Bowen EP. Physiological compartmental model describing the dynamics of lycopene metabolism in healthy men. J Lipid Res 2003;44:1927-39.
25. Miettinen PJ, Ustinov J, Ormio P, Gao R, Palgi J, Hakonen E, Juntti-Berggren L, Berggren P, Otonkoski T. Downregulation of EGF receptor signaling in pancreatic islets causes diabetes due to impaired postnatal β-cell growth. Diabetes 2006;55:3299-308.
26. Wolf SP. Ferrus ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. Meth Enzymol 1994;233:182-9.
27. -/- mice to study metallothionein and oxidative stress. Free Rad Biol Med 2000;28:447-62.
28. Granger DL, Taintor RR, Boockvar KS. Determination of nitrate and nitrite in biological samples using bacterial nitrate reductase coupled with the Griess reaction. Methods Companion Meth Enzymol 1995;7:78-83.
29. Aebi H. Catalase. Method of enzymatic analysis. New York: Academic Press; 1984.
30. Marklund S, Marklund G. Involvement of superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974;47: 469-74.
31. Paglia ED, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocytes glutathione peroxidase. J Lab Clin Med 1967;70:158-69.
32. Soto CO, Perez BL, Favari LP, Reyes JL. Prevention of alloxan-induced diabetes mellitus in the rat by silymarin. Comp Biochem Physiol 1988;119C:125-30.
33. Jeon SM, Song SH, Jang MK, Kim YH, Nam KT, Jeong TS, Park YB, Choi MS. Comparison of antioxidant effects of naringin and probucol in cholesterol-fed rabbits. Clin Chem Acta 2002;317:181-90.
34. Hunt JV, Smith CC, Wolf SP. Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification of glucose. Diabetes 1990;39:1420-4.
35. Haluzik M, Nedvidkova J. The role of nitric oxide in the development of streptozotocin-induced diabetes mellitus: experimental and clinical implications. Physiol Res 2000;49: 37-42.
36. Tsai EG, Hirsch IB, Brunzell JD, Chait A. Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDD. Diabetes 1994;43:1010-14.
37. Baynes JW. Reactive oxygen in the aetiology and complications of diabetes. In: Ioannides C, Flatt PR, editors. Drug, diet, and disease. Mechanistic approach to diabetes. Hertfordshire: Ellis Horwood; 1995.
38. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction? Diabetes 2003;52:1-8.
39. Laight DW, Carrier MJ, Anggard EE. Antioxidants, diabetes, and endothelial dysfunction. Cardiovasc Res 2000;47:457-64.
40. Piconi L, Quagliara L, Ceriello A. Oxidative stress in diabetes. Clin Chem Lab Med 2003;41:1144-9.
41. Escobar JA, Rubio MA, Lissi EA. SOD and catalase inactivation by singlet oxygen and peroxyl radicals. Free Rad Biol Med 1996;20:285-90.
42. Blum J, Fridovich I. Inactivation of glutathione peroxidase by superoxide radical. Arch Biochem Biophys 1985;240:500-8.
43. Kono Y, Fridovich I. Superoxide radical inhibits catalase. J Biol Chem 1982;257:5751-4.
44. Sowers JR. Hyperglycemia-related alterations in vascular nitric oxide production. J Diabetes Complications 2001;15:6-14.
45. Gary A, Grundy SM. Management of dyslipidemia in NIDDM. Diabetes Care 1990;13:153-69.
46. Levey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, Kasiske BL, Klag MJ, Mailloux LU, Manske CL, Meyer KB, Parfrey PS, Pfeffer MA, Wenger NK, Wilson PW, Wright JT Jr. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? Am J Kidney Dis 1998;32:853-906.
47. Mulec H, Johnson SA, Bjorck S. Relation between serum cholesterol and diabetic nephropathy. Lancet 1990;335: 1537-8.
48. Laakso M. Glycemic control and the risk of coronary heart disease in patients with non-insulin-dependent-diabetes-melli-tus. The Finnish studies. Am J Clin Nutr 1996;124:127-30.
49. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Despres JP. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: prospective results from the Quebec cardiovascular study. Circulation 1997;95:69-75.
50. Britton G. Structure and properties of carotenoids in relation to function. FASEB J 1995;9:1551-8.
51. DiMascio P, Kaiser S, Sies H. Lycopene as the most effective biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 1989;274:532-8.
52. Reifen R, Nissenkorn A, Matas Z, Bujanover Y. 5-ASA and lycopene decrease the oxidative stress and inflammation induced by iron in rats with colitis. J Gastroenterol 2004;39: 514-19.
53. Stahl W, Sies H. Antioxidant activity of carotenoids. Mol Aspects Med 2003;24:345-51.
54. Wertz K, Siler U, Goralczyk R. Lycopene: modes of action to promote prostate health. Arch Biochem Biophys 2004;430: 127-34.
55. El-Missiry MA, El-Gindy AM. Amelioration of alloxan induced diabetes mellitus and oxidative stress in rats by oil of Eruca sativa seeds. Ann Nutr Metab 2000;44:97-100.
56. 2 in human umbilical vein endothelial cells cultured in high glucose medium. Diabetologia 1994;32:264-9.
57. Sinclair AJ. Free radical mechanisms and vascular complications of diabetes mellitus. Diabetes Rev 1993;2:7-10.
58. Togashi H, Shinzawa H, Wakabayashi H, Nakamura T, Yamada N, Takahashi T, Ishikawa M. Activities of free oxygen radical scavenger enzymes in human liver. J Hepatol 1990;11:200-5.
59. Fuhrman B, Elis A, Aviram M. Hypocholesterolemic effect of lycopene and beta-carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophages. Biochem Biophys Res Commun 1997;233:658-62.
60. Agarwal S, Rao AV. Tomato lycopene and low density lipoprotein oxidation: a human dietary intervention study. Lipids 1998;33:981-4.
61. Heber D, Yi lu Q. Overview of mechanisms of action of lycopene. Exp Biol Med 2002;227:920-3.